323 related articles for article (PubMed ID: 21902810)
21. Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.
Condello S; Sima L; Ivan C; Cardenas H; Schiltz G; Mishra RK; Matei D
Cancer Res; 2018 Jun; 78(11):2990-3001. PubMed ID: 29510995
[TBL] [Abstract][Full Text] [Related]
22. Tissue transglutaminase: a multifunctional and multisite regulator in health and disease.
Yao Z; Fan Y; Lin L; Kellems RE; Xia Y
Physiol Rev; 2024 Jan; 104(1):281-325. PubMed ID: 37712623
[TBL] [Abstract][Full Text] [Related]
23. Cellular functions of tissue transglutaminase.
Nurminskaya MV; Belkin AM
Int Rev Cell Mol Biol; 2012; 294():1-97. PubMed ID: 22364871
[TBL] [Abstract][Full Text] [Related]
24. Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.
Espitia Pinzón N; Brevé JJP; Bol JGJM; Drukarch B; Baron W; van Dam AM
J Neuroinflammation; 2017 Dec; 14(1):260. PubMed ID: 29282083
[TBL] [Abstract][Full Text] [Related]
25. Enhanced neural differentiation of neural stem cells by sustained release of Shh from TG2 gene-modified EMSC co-culture in vitro.
Shi W; Bian L; Lv D; Bi S; Dai Y; Yang K; Lu H; Zhou H; Que Y; Wang D; Zhang Z; Lu N
Amino Acids; 2021 Jan; 53(1):11-22. PubMed ID: 33245424
[TBL] [Abstract][Full Text] [Related]
26. Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.
Yi MC; Melkonian AV; Ousey JA; Khosla C
J Biol Chem; 2018 Feb; 293(8):2640-2649. PubMed ID: 29305423
[TBL] [Abstract][Full Text] [Related]
27. TG2, a novel extracellular protein with multiple functions.
Wang Z; Griffin M
Amino Acids; 2012 Feb; 42(2-3):939-49. PubMed ID: 21818567
[TBL] [Abstract][Full Text] [Related]
28. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?
van Strien ME; Brevé JJ; Fratantoni S; Schreurs MW; Bol JG; Jongenelen CA; Drukarch B; van Dam AM
PLoS One; 2011; 6(9):e25037. PubMed ID: 21949843
[TBL] [Abstract][Full Text] [Related]
29. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
[TBL] [Abstract][Full Text] [Related]
30. Structural aspects of transglutaminase 2: functional, structural, and regulatory diversity.
Lee CS; Park HH
Apoptosis; 2017 Sep; 22(9):1057-1068. PubMed ID: 28677093
[TBL] [Abstract][Full Text] [Related]
31. Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion.
Balklava Z; Verderio E; Collighan R; Gross S; Adams J; Griffin M
J Biol Chem; 2002 May; 277(19):16567-75. PubMed ID: 11867617
[TBL] [Abstract][Full Text] [Related]
32. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
[TBL] [Abstract][Full Text] [Related]
33. Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex.
Wang Z; Telci D; Griffin M
Exp Cell Res; 2011 Feb; 317(3):367-81. PubMed ID: 21036168
[TBL] [Abstract][Full Text] [Related]
34. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.
Forsprecher J; Wang Z; Nelea V; Kaartinen MT
Amino Acids; 2009 Apr; 36(4):747-53. PubMed ID: 18604470
[TBL] [Abstract][Full Text] [Related]
35. Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies.
Cardoso I; Stamnaes J; Andersen JT; Melino G; Iversen R; Sollid LM
FEBS J; 2015 Jun; 282(11):2063-75. PubMed ID: 25808416
[TBL] [Abstract][Full Text] [Related]
36. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin.
Akimov SS; Krylov D; Fleischman LF; Belkin AM
J Cell Biol; 2000 Feb; 148(4):825-38. PubMed ID: 10684262
[TBL] [Abstract][Full Text] [Related]
37. Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions.
Diaz-Hidalgo L; Altuntas S; Rossin F; D'Eletto M; Marsella C; Farrace MG; Falasca L; Antonioli M; Fimia GM; Piacentini M
Biochim Biophys Acta; 2016 Aug; 1863(8):2084-92. PubMed ID: 27169926
[TBL] [Abstract][Full Text] [Related]
38. Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?
van Strien ME; Drukarch B; Bol JG; van der Valk P; van Horssen J; Gerritsen WH; Breve JJ; van Dam AM
Brain Pathol; 2011 Jan; 21(1):44-54. PubMed ID: 20731658
[TBL] [Abstract][Full Text] [Related]
39. Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.
Lortat-Jacob H; Burhan I; Scarpellini A; Thomas A; Imberty A; Vivès RR; Johnson T; Gutierrez A; Verderio EA
J Biol Chem; 2012 May; 287(22):18005-17. PubMed ID: 22442151
[TBL] [Abstract][Full Text] [Related]
40. Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.
Kumar A; Xu J; Sung B; Kumar S; Yu D; Aggarwal BB; Mehta K
Breast Cancer Res; 2012 Jan; 14(1):R4. PubMed ID: 22225906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
